S&U plc (SUS)
London Stock Exchange · UK · prices in GBX · close of 27 Oct 2026
Key indicators
| Last close | GBX 1,910.00 |
|---|---|
| 52-week range | 1,665.00 – 2,458.50 |
| Return, 1 month / 3 months | −2.4% / −0.2% |
| Return, 1 year / 3 years | +19.2% / +11.6% |
| Trend | Below its 200-day average |
| RSI (14) | 52 |
| Volatility (1 year) | 29.7% |
| Worst drawdown (1 year) | -24.6% |
| Average daily value traded | 10.74M GBX |
| Dividend yield | 7.9% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
S&U plc is a British specialist lender based in the United Kingdom. Through its motor finance arm it provides hire purchase and conditional sale agreements to customers buying used cars, many of whom are not served by mainstream banks. A separate division offers short-term bridging loans secured against property. The company funds its lending through its own resources and borrowings, and deals directly with consumers and motor dealers rather than with large corporate clients.
The shares are listed on the London Stock Exchange in UK under the code SUS, and the price on this page is in pence sterling (GBX). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
S&U plc (SUS) trades on the London Stock Exchange in UK. It last closed at GBX 1,910.00 on 27 October 2026.
Its price-based Market X-Ray is 61 out of 100 (a fair price profile), ranking 1,220 of 3,788 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 19.2% and over the last three months it fell 0.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 42 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -2.2% | ||
| From 52-week high | -20.7% | ||
| Momentum | 61 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -0.2% | ||
| 6-month return | 6.0% | ||
| 12-month return, skipping the last month | 22.2% | ||
| Stability (higher is calmer) | 62 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 29.7% | ||
| Worst drawdown, 1 year (smaller is calmer) | -24.6% | ||
| Liquidity | 75 · Strong | Trades actively. | |
| Average daily value traded | 10.74M GBX | ||
| Zero-volume days | 0.0% | ||
| Income | 88 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 7.9% | ||
| Years with dividends | 6 |
Strengths
- Liquidity: Trades actively.
- Income: Dividend is high and has been paid regularly.
Weak spots
- Trend: Below its long-term averages and far from its highs.
Returns
| 1 week | +0.3% |
|---|---|
| 1 month | −2.4% |
| 3 months | −0.2% |
| 6 months | +6.0% |
| 1 year | +19.2% |
| 3 years | +11.6% |
| 5 years | −10.8% |
Signals
| 50-day / 200-day average | 1,918.69 / 1,952.59 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 63.36 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 8 Oct 2026 | GBP 0.3600 |
| 2 Jul 2026 | GBP 0.4500 |
| 19 Feb 2026 | GBP 0.3500 |
| 30 Oct 2025 | GBP 0.3500 |
| 3 Jul 2025 | GBP 0.4000 |
| 13 Feb 2025 | GBP 0.3000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.